143 related articles for article (PubMed ID: 34950321)
1. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis.
J Singleton M; Y Chen L; Whalen SP; D Bhave P; H Beaty E; Yeboah J; Z Soliman E
J Atr Fibrillation; 2020 Dec; 13(4):2401. PubMed ID: 34950321
[TBL] [Abstract][Full Text] [Related]
2. Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation.
Soliman EZ; Rahman AF; Zhang ZM; Rodriguez CJ; Chang TI; Bates JT; Ghazi L; Blackshear JL; Chonchol M; Fine LJ; Ambrosius WT; Lewis CE
Hypertension; 2020 Jun; 75(6):1491-1496. PubMed ID: 32362229
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
[TBL] [Abstract][Full Text] [Related]
4. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.
Chen LY; Bigger JT; Hickey KT; Chen H; Lopez-Jimenez C; Banerji MA; Evans G; Fleg JL; Papademetriou V; Thomas A; Woo V; Seaquist ER; Soliman EZ
Am J Hypertens; 2016 Nov; 29(11):1276-1282. PubMed ID: 26476086
[TBL] [Abstract][Full Text] [Related]
5. Tight versus standard blood pressure control in patients with hypertension with and without cardiovascular disease.
Reboldi G; Angeli F; de Simone G; Staessen JA; Verdecchia P;
Hypertension; 2014 Mar; 63(3):475-82. PubMed ID: 24343119
[TBL] [Abstract][Full Text] [Related]
6. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
7. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population.
Cardio-Sis Study Group
J Hum Hypertens; 2008 Apr; 22(4):243-51. PubMed ID: 18046432
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure targets for hypertension in people with diabetes mellitus.
Arguedas JA; Leiva V; Wright JM
Cochrane Database Syst Rev; 2013 Oct; (10):CD008277. PubMed ID: 24170669
[TBL] [Abstract][Full Text] [Related]
9. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.
Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
Diabetes Care; 2017 Dec; 40(12):1733-1738. PubMed ID: 28947569
[TBL] [Abstract][Full Text] [Related]
10. More Versus Less Blood Pressure Lowering: An Update.
Atkins ER; Rodgers A
Clin Ther; 2016 Oct; 38(10):2135-2141. PubMed ID: 27633256
[TBL] [Abstract][Full Text] [Related]
11. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.
Beddhu S; Greene T; Boucher R; Cushman WC; Wei G; Stoddard G; Ix JH; Chonchol M; Kramer H; Cheung AK; Kimmel PL; Whelton PK; Chertow GM
Lancet Diabetes Endocrinol; 2018 Jul; 6(7):555-563. PubMed ID: 29685860
[TBL] [Abstract][Full Text] [Related]
12. Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation: insights from the SPRINT trial.
Jiang C; Lai Y; Du X; Wang Y; Li S; He L; Hu R; Lv Q; Wu J; Feng L; Ning M; Ruan Y; Li X; Jia C; Dai W; Guo X; Jiang C; Tang R; Sang C; Long D; Arima H; Dong J; Anderson CS; Ma C
Europace; 2022 Oct; 24(10):1560-1568. PubMed ID: 35640916
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of a Simple Algorithm to Identify Hypertensive Patients Who Benefit from Intensive Blood Pressure Lowering.
Wang S; Khera R; Das SR; Vigen R; Wang T; Luo X; Lu R; Zhan X; Xiao G; Vongpatanasin W; Xie Y
Am J Cardiol; 2018 Jul; 122(2):248-254. PubMed ID: 29880288
[TBL] [Abstract][Full Text] [Related]
14. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
[TBL] [Abstract][Full Text] [Related]
15. A prospective study on the association between atrial fibrillation and blood pressure in an elderly Chinese population.
Chen Y; Zhang W; Sheng CS; Huang QF; Cheng YB; Guo QH; Zhang DY; Li Y; Freedman B; Wang JG
Int J Cardiol; 2023 Feb; 372():113-119. PubMed ID: 36513285
[TBL] [Abstract][Full Text] [Related]
16. Optimal blood pressure targets for patients with hypertension: a systematic review and meta-analysis.
Sakima A; Satonaka H; Nishida N; Yatsu K; Arima H
Hypertens Res; 2019 Apr; 42(4):483-495. PubMed ID: 30948822
[TBL] [Abstract][Full Text] [Related]
17. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials.
Boulouis G; Morotti A; Goldstein JN; Charidimou A
J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):339-345. PubMed ID: 28214798
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.
Ho MJ; Li EC; Wright JM
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007435. PubMed ID: 26935713
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
